Not applicableStudy completedNCT02330510
What this trial is testing
Amyloid and Glucose PET Imaging in Alzheimer and Vascular Cognitive Impairment Patients With Significant White Matter Disease
Who this might be right for
Alzheimer's DiseaseSmall Vessel Disease White Matter Hyperintensities SubtypeVascular Cognitive Impairment
Dr. Sandra E Black 80